title: Comparison of the Protective Effect of Indole beta-carbolines and R-(-)-deprenyl Against Nitrogen Species-Induced Cell Death in Experimental Culture Model of Parkinson's Disease.
abstract: BACKGROUND
  The membrane permeability transition of mitochondria has been suggested to be involved in toxic and oxidative forms of cell injury. Mitochondrial dysfunction is considered to play a critical role in neurodegeneration in Parkinson's disease. Despite the suggestion that indole beta-carbolines may be neurotoxic, these compounds provide a protective effect against cytotoxicity of other neurotoxins. In addition, the effect of indole beta-carbolines on change in the mitochondrial membrane permeability due to reactive nitrogen species (RNS), which may lead to cell death, has not been clarified.
  
  
  METHODS
  Differentiated PC12 cells were used as the experimental culture model for the investigation of neuronal cell injury, which occurs in Parkinson's disease. The effect of indole beta-carbolines (harmalol and harmine) on differentiated PC12 cells against toxicity of S-nitroso-N-acetyl-DL-penicillamine (SNAP) was determined by measuring the effect on the change in transmembrane potential, cytochrome c release, formation of ROS, GSH contents, caspase-3 activity and cell viability, and was compared to that of R-(-)-deprenyl.
  
  
  RESULTS
  Specific inhibitors of caspases (z-LEHD.fmk, z-DQMD.fmk) and antioxidants (N-acetylcysteine, dithiothreitol, melatonin, carboxy-PTIO and uric acid) depressed cell death in PC12 cells due to SNAP. beta-Carbolines and R-(-)-deprenyl attenuated the SNAP-induced cell death and GSH depletion concentration dependently with a maximal inhibitory effect at 25-50 microM. The compounds inhibited the nuclear damage, decrease in mitochondrial transmembrane potential, cytochrome c release and formation of reactive oxygen species caused by SNAP in PC12 cells. beta-Carbolines and R-(-)-deprenyl attenuated the H(2)O(2)-induced cell death and depletion of GSH.
  
  
  CONCLUSIONS
  The results suggest that indole beta-carbolines attenuate the SNAP-induced viability loss in PC12 cells by inhibition of change in the mitochondrial membrane permeability, which may be caused by free radicals. Indole beta-carbolines appear to exert a protective effect against the nitrogen species-mediated neuronal cell injury in Parkinson's disease comparable to R-(-)-deprenyl.
authors.affiliation: Department of Neurology, Seoul Veterans Hospital, Seoul, Korea.
authors.forename: Young-Su
authors.initials: YS
authors.lastname: Han
authors.forename: Jung-Mee
authors.initials: JM
authors.lastname: Kim
authors.forename: Jeong-Seon
authors.initials: JS
authors.lastname: Cho
authors.forename: Chung Soo
authors.initials: CS
authors.lastname: Lee
authors.forename: Doo-Eung
authors.initials: DE
authors.lastname: Kim
references.citation: Med Biol. 1981 Feb;59(1):21-34
references.pmid: 7022042
references.citation: J Neurochem. 2004 Sep;90(6):1281-9
references.pmid: 15341512
references.citation: Free Radic Biol Med. 1997;22(3):525-34
references.pmid: 8981045
references.citation: Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8
references.pmid: 12666096
references.citation: Free Radic Biol Med. 1997;23(7):1055-66
references.pmid: 9358249
references.citation: J Neurochem. 1994 Apr;62(4):1503-10
references.pmid: 8133278
references.citation: J Histochem Cytochem. 1996 Sep;44(9):989-96
references.pmid: 8773564
references.citation: Nat Med. 1996 Sep;2(9):1017-21
references.pmid: 8782460
references.citation: Neurochem Int. 2003 Jul;43(2):147-54
references.pmid: 12620283
references.citation: J Neural Transm. 1985;64(2):113-27
references.pmid: 3935752
references.citation: J Biol Chem. 2000 Jan 28;275(4):2455-62
references.pmid: 10644699
references.citation: J Neurosci. 1996 Oct 15;16(20):6394-401
references.pmid: 8815918
references.citation: Neurobiol Dis. 1998 Oct;5(4):229-43
references.pmid: 9848093
references.citation: J Pharmacol Exp Ther. 2002 May;301(2):753-64
references.pmid: 11961082
references.citation: Am J Physiol. 1995 May;268(5 Pt 1):L699-722
references.pmid: 7762673
references.citation: Biochem Pharmacol. 1986 Aug 1;35(15):2636-9
references.pmid: 3741463
references.citation: J Pharm Pharmacol. 1994 Oct;46(10):809-13
references.pmid: 7699568
references.citation: Arch Toxicol. 1993;67(4):290-3
references.pmid: 8517786
references.citation: Neurology. 1996 Dec;47(6 Suppl 3):S171-83
references.pmid: 8959986
references.citation: Neurosci Res. 2002 Nov;44(3):255-65
references.pmid: 12413654
references.citation: Ann N Y Acad Sci. 2000;899:255-61
references.pmid: 10863544
references.citation: Free Radic Biol Med. 2003 Feb 1;34(3):287-303
references.pmid: 12543245
references.citation: J Biol Chem. 1999 Oct 29;274(44):31185-8
references.pmid: 10531311
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: J Neurochem. 1998 Feb;70(2):727-35
references.pmid: 9453568
references.citation: Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5408-12
references.pmid: 1608949
references.citation: J Neuropathol Exp Neurol. 1998 Apr;57(4):338-42
references.pmid: 9600227
references.citation: Free Radic Biol Med. 2000 Mar 1;28(5):743-53
references.pmid: 10754270
references.citation: Eur J Neurosci. 2001 May;13(10):1861-72
references.pmid: 11403679
references.citation: Neurology. 1995 Dec;45(12):2240-5
references.pmid: 8848200
references.citation: Neuroscience. 1993 Jul;55(2):303-10
references.pmid: 8377927
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(23):9368-72
references.pmid: 2251279
references.citation: Biochem Pharmacol. 1991 Jul 15;42(3):459-64
references.pmid: 1859459
references.citation: Free Radic Biol Med. 2000 Aug;29(3-4):323-33
references.pmid: 11035261
references.citation: J Neurochem. 2000 Oct;75(4):1455-64
references.pmid: 10987825
references.citation: Neuroscience. 1996 May;72(2):355-63
references.pmid: 8737406